Magnetic Correction of Eye Lid Paralysis

Status Completed

Clinical Trial Summary

Objective 1: Determine the safety and feasibility of externally mounted magnets for extended management of chronic eyelid movement disorders by measuring visual acuity and corneal and skin integrity and comfort over 8 weeks of wear. Objective 2: Collect preliminary data on the relative efficacy of external magnetic devices by comparing them to externally mounted lid weights and ptosis crutches using rating scales and video analysis of blink biomechanics.

Clinical Trial Description

Two major types of eye lid movement disorders include lagophthalmos (incomplete closure of the eyelids) and blepharoptosis (incomplete opening of the eyelids). Both of these conditions occur because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. Generally paralysis of the eyelid or facial muscles is responsible for the abnormality (the eyelids can close but not open, or open but not close). An external device, if able to generate an appropriately balanced force, could restore eyelid movement by performing the paralyzed function; for example, a ptotic (droopy) eyelid could be opened, and the functioning eyelid closure muscle could overcome the device's force. In prior work the investigators established proof-of-concept data demonstrating safety and efficacy for temporary management of ptosis up to 2 hour per day for 2 weeks. Preliminary data suggest similar safety for lagophthalmos. This study will expand on this preliminary work to examine longer wear times, home use, and feasibility for a wider range of eye lid disorders. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02988856
Study type	Interventional
Source	Massachusetts Eye and Ear Infirmary
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2015
Completion date	May 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00864656` - Eyelid Position Interdependence in Involutional Ptosis Patients Submitted to 10% Phenylephrine	N/A
Recruiting	`NCT02959697` - Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair	N/A
Recruiting	`NCT02501187` - Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair	N/A
Completed	`NCT00793988` - Vibration-Assisted Anaesthesia	Phase 4
Completed	`NCT02367677` - Digital Photographs to Evaluate Blepharoptosis	N/A
Recruiting	`NCT01239498` - Saline Injection - Assisted Anesthesia in Eyelid Surgery	Phase 4
Not yet recruiting	`NCT05358977` - Fibrin Sealant in Eyelid Surgery	Phase 2/Phase 3
Completed	`NCT01848041` - Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis	Phase 1/Phase 2
Completed	`NCT01350024` - Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid	N/A
Completed	`NCT06047418` - Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
Active, not recruiting	`NCT03149367` - Surgical Management of Blepharoptosis	N/A
Completed	`NCT03565887` - Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis	Phase 3
Recruiting	`NCT01968174` - Astigmatic Changes Secondary to Eyelid Surgeries	N/A
Completed	`NCT03536949` - Study of Safety of RVL-1201 in Treatment of Blepharoptosis	Phase 3
Recruiting	`NCT04678115` - Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis	N/A
Not yet recruiting	`NCT04235803` - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery	N/A
Terminated	`NCT03239418` - NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy	N/A
Not yet recruiting	`NCT02638610` - Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries	N/A
Enrolling by invitation	`NCT05945615` - Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis	Phase 3
Recruiting	`NCT06292182` - Red Light Ptosis Proof-of-Concept	N/A